In Silico and In Vitro: Identifying New Drugs

Current Drug Targets

Volumn 9, Issue 12, 2008, Pages 1054-1061

  Pauli, Ivani ^a   Timmers, Luis Fernando Saraiva Macedo ^a   Caceres, Rafael Andrade ^a   Soares, Milena Botelho Pereira ^b   de Azevedo Jr , Walter Filgueira ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Drug development; In silico screening; In vitro screening; Pharmacokinetics; Protein target

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; DRUG; PROTEIN; PROTEINASE INHIBITOR;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; IN VITRO STUDY; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; DRUG DESIGN; HIV PROTEASE INHIBITORS; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 61449142858     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945008786949397     Document Type: Review

References (94)

1. Yin, H. and Hamilton, A.D. (2005) Angew Chem. Int. Ed. Engl., 44(27), 4130-4163.
2. Lipinski, C. and Hopkins A. (2004) Nature, 432(7019), 855-861.
3. Zheng, C.; Han, L.; Yap, C.W.; Xie, B. and Chen, Y. (2006) Drug Discov. Today, 11(9-10), 412-420.
4. Harris, C.J. and Stevens, A.P. (2006) Drug Discov. Today, 11(19-20), 880-888.
5. Hall, S.E. (2006) Drug Discov. Today, 11(11-12), 495-502.
6. Stockwell, B.R. (2004) Nature, 432(7019), 846-854.
7. Bleicher, K.H.; Böhm, H.J.; Muller, K. And Alanine, A.I. (2003) Nat. Rev. Drug Discov., 2(5), 369-378.
8. Kennedy, T. (1997) Drug Disc. Today, 2, 436-444.
9. van de Waterbeemd, H. and Gifford, E. (2003) Nat. Rev. Drug Discov., 2(3), 192-204.
10. Baranczewski, P.; Stanczak, A.; Sundberg, K.; Svensson, R.; Wallin, A.; Jansson, J.; Garberg, P. and Postlind, H. (2006) Pharmacol. Reports, 58(4), 453-472.
11. Dambach, D.M.; Andrews, B.A. and Moulin, F. (2005) Toxicol. Pathol., 33(1), 17-26.
12. Nwaka, S. and Hudson, A. (2006) Nat. Rev. Drug Discov., 5(11), 941-955
13. Lipinski, C.A.; Lombardo, F.; Dominy, B.W. and Feeney, P.J. (2001) Adv. Drug Deliv. Rev., 46(1-3), 3-26.
14. De Azevedo, W.F.; Mueller-Dieckmann, H.J.; Schulze-Gahmen, U.; Worland, P.J.; Sausville, E. and Kim, S.H. (1996) Proc. Natl. Acad. Sci. USA, 93(7), 2735-2740.
15. De Azevedo, W.F.; Leclerc, S.; Meijer, L.; Havlicek, L.; Strnad, M. and Kim, S. H. (1997) Eur. J. Biochem., 243(1-2), 518-526.
16. Canduri, F. and De Azevedo, W.F. Jr. (2005) Curr. Computer-Aided Drug Design, 1(1), 53-64.
17. Canduri, F.; Perez, P.C.; Caceres, R.A. and de Azevedo, W.F. Jr. (2008) Med. Chem., 4(3), 210-218.
18. De Azevedo, W.F.; Canduri, F.; Santos, D.M.; Silva, R.G.; Oliveira, J.S.; Carvalho, L.P.S.; Basso, L.A.; Mendes, M.A.; Palma, M.S. and Santos, D.S. (2003) Biochem. Biophys. Res. Commun., 308(3), 545-552.
19. Santos, D.M.; Canduri, F.; Pereira, J.H.; Dias, M.V.B.; Silva, R.G.; Mendes, M.A.; Palma, M.S.; Basso, L.A.; De Azevedo, W.F. and Santos, D.S. (2003) Biochem. Biophys. Res. Commun., 308(3), 553-559.
20. De Azevedo, W.F.; Canduri, F.; Dos Santos, D.M.; Pereira, J.H.; Dias, M.V.B.; Silva, R.G.; Mendes, M.A.; Basso, L.A.; Palma, M.S. and Santos, D.S. (2003) Biochem. Biophys. Res. Commun., 309(4), 917-922.
21. Canduri, F.; Fadel, V.; Dias, M.V.B.; Basso, L.A.; Palma, M.S.; Santos, D.S. and De Azevedo, W.F. Jr. (2005) Biochem. Biophys. Res. Commun., 326(3), 335-338.
22. Canduri, F.; Fadel, V.; Basso, L.A.; Palma, M.S.; Santos, D.S. and De Azevedo, W.F. Jr. (2005) Biochem. Biophys. Res. Commun. 327(3), 646-649.
23. Canduri, F.; Silva, R.G.; dos Santos, D.M.; Palma, M.S.; Basso, L.A.; Santos, D.S. and De Azevedo, W.F. Jr. (2005) Acta. Crystallogr. D. Biol. Crystallogr. 61(7), 856-862.
24. Davis, A.M.; Teague, S.J. and Kleywegt, G.J. (2003) Angew Chem. Int. Ed. Engl., 42(24), 2718-2736.
25. Jahnke, W. (2007) J. Biomol. NMR, 39(2), 87-90.
26. Babaoglu, K. and Shoichet, B.K. (2006) Nat. Chem. Biol., 2(12), 720-723.
27. Anderson, A.C. (2003) Chem. Biol., 10(9), 787-797.
28. Takeuchi, K. and Wagner, G. (2006) Curr. Opin. Struct. Biol., 16(1), 109-117.
29. Davies, J.W.; Glick, M. and Jenkins, J.L. (2006) Curr. Opin. Chem. Biol., 10(4), 343-351.
30. Stevens, R.C. (2003) Drug Discov. World, 4(1), 35-48.
31. Whitty, A. and Kumaravel G. (2006) Nat. Chem. Biol., 2(3), 112-118.
32. Collins, I. and Workman, P. (2006) Nat. Chem. Biol., 2(12), 689-700.
33. Arkin, M. (2005) Curr. Opin. Chem. Biol., 9(3), 317-324.
34. Timmers, L.F.S.M.; Caceres, R.A.; Vivan, A.L.; Gava, L.M.; Dias, R.; Ducati, R.; Basso, L.A.; Santos, D.S. and de Azevedo, W.F. Jr. (2008) Arch. Biochem. Biophys., 479(1), 28-38.
35. Schneider, G. and Baringhaus, K.H. (2008) in Molecular Design. Concepts and Applications. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
36. Irwin, J.J. and Shoichet, B.K. (2005) J. Chem. Inf. Model., 45(1), 177-182.
37. Veber, D.F.; Johnson, S.R.; Cheng, H.Y.; Smith, B.R.; Ward, K.W. and Kopple, K.D. (2002) J. Med. Chem., 45(12), 2615-2623
38. Clark, D.E. and Picket, S.D. (2000) Drug Discov. Today, 5(2), 49-58
39. Janssen, D. (2002) Curr. Drug Disc., 1(1), 38-40.
40. Podlogar, B.L.; Muegge, I. and Brice L.J. (2001) Curr. Opin. Drug Disc. Dev. 4(1), 102-109.
41. Ekins, S.; Waller, C.L.; Swaan, P.W.; Cruciani, G.; Wrighton, S.A. and Wikel, J.H. (2001) J. Pharmacol. Toxicol. Methods, 44 (1), 251-272.
42. Ekins, S. and Wrighton, S.A. (2001) J. Pharmacol. Toxicol. Methods, 45(1), 65-69.
43. Rodrigues, A.D.; Winchell, G.A. and Dobrinska, M.R. (2001) J. Clin. Pharmacol., 41(4), 368-373.
44. Bachman, K.A. and Ghosh, R. (2001) Curr. Drug Metab., 2(3), 299-314.
45. Selick, H.E.; Beresford, A.P. and Tarbit, M.H. (2002) Drug Disc. Today, 7(2), 109-116.
46. Greer, J.; Erickson, J.W.; Baldwin, J.J. and Varney, M.D. (1994) J. Med. Chem., 37(8), 1035-1054.
47. Leach, A.R. (2001) in Molecular modeling: principles and applications, 2nd edn. Pearson Education, London.
48. Navia, M.A. and Murcko, M.A. (1992) Curr. Opin. Struct. Biol., 2(1), 202-216.
49. Sun, H. (2008) Curr. Med. Chem. 15(10), 1018-1024.
50. van de Waterbeemd H. and Rose S. (2003) in The Practice of Medicinal Chemistry 2nd (Wermuth, L. G., Ed) (Academic Press) pp. 1367-1385.
51. van de Waterbeemd H. (2002) Curr. Opin. Drug Disc. Dev. 5(1), 33-43.
52. Clark, D.E. and Grootenhuis, P.D. (2002) Curr. Opin. Drug Disc. Dev., 5(3), 382-390.
53. Demel, M.A.; Schwaha, R.; Krämer, O.; Ettmayer, P.; Haaksma, E.E.; and Ecker, G.F. (2008) Expert Opin. Drug. Metab. Toxicol., 4(9), 1167-1180.
54. Khan, M.T. and Sylte, I. (2007) Curr. Drug Discov. Technol., 4(3), 141-149.
55. Dearden, J.C. (2007) Expert Opin. Drug Metab. Toxicol., 3(5), 635-639.
56. Mohan, C.G.; Gandhi, T.; Garg, D. and Shinde, R. (2007) Mini Rev. Med. Chem., 7(5), 499-507.
57. Norinder, U. and Bergström, C.A. (2006) Chem. Med. Chem. 1(9), 920-937.
58. Stumpf, W.E. (2005) J. Pharmacol. Toxicol. Methods, 51(1), 25-40.
59. Patric, G.L. (2005) in An Introduction to Medicinal Chemistry-Antiviral Agents. Oxford University Press Inc., New York. pp. 440-488.
60. Blackburn, T.P.; Suzuki, K. and Ashby, C.R. Jr. (2006) Synapse, 59(8), 502-512.
61. Bromidge, S.M.; Dabbs, S.; Davies, D.T.; Davies, S.; Duckworth, D.M.; Forbes, I.T.; Gadre, A.; Ham, P.; Jones, G.E.; King, F.D.; Saunders, D.V.; Thewlis, K.M.; Vyas, D.; Blackburn, T.P.; Holland, V.; Kennett, G.A.; Riley, G.J.; and Wood, M.D. (1999) Bioorg. Med. Chem., 7(12), 2767-2773.
62. Bromidge, S.M.; Dabbs, S.; Davies, D.T.; Duckworth, D.M.; Forbes, I.T.; Ham, P.; Jones, G.E.; King, F.D.; Saunders, D.V.; Starr, D.; Thewlis, K.M.; Wyman, P.A.; Blaney, F.E.; Naylor, C.B.; Bailey, F.; Blackburn, T.P.; Holland, V.; Kennett, G.A.; Riley, G.J. and Wood, M.D. (1998) J. Med. Chem., 41(10), 1598-1612.
63. Bromidge, S.M.; Duckworth, M.; Forbes, I.T.; Ham, P.; King, F.D.; Thewlis, K.M.; Blaney, F.E.; Naylor, C.B.; Blackburn, T.P.; Kennett, G.A.; Wood, M.D. and Clarke, S.E. (1997) J. Med. Chem., 40(22), 3494-3496.
64. Bromidge, S.M.; Dabbs, S.; Davies, D.T.; Davies, S.; Duckworth, D.M.; Forbes, I.T.; Gaster, L.M.; Ham, P.; Jones, G.E.; King, F.D.; Mulholland, K.R.; Saunders, D.V.; Wyman, P.A.; Blaney, F.E.; Clarke, S.E.; Blackburn, T.P.; Holland, V.; Kennett, G.A.; Lightowler, S.; Middlemiss, D.N.; Trail, B.; Riley, G.J. and Wood, M.D. (2000) J. Med. Chem. 43(6), 1123-1134.
65. Kempen, J.H. (2008) Indian J. Ophthalmol., 56(5), 385-90.
66. Centers for Disease Control. Pneumocytis pneumonia-Los Angeles. (1981) MMWR Morb Mortal Wkly Rep., 30, 250-252.
67. UNAIDS Annual Report 2007: Know Your Epidemic. UNAIDS, Geneva, Available at:/data. unaids. org/pub/Report/2008/jcl1535_annual_report07_en. pdf
68. Whittle, P.J. and Blundell, T.L. (1994) Annu. Rev. Biophys. Biomol. Struct., 23, 349-379.
69. Blundell, T.L.; Lapatto, R.; Wilderspin, A.F.; Hemmings, A.M.; Hobart, P.M.; Danley, D. E; Whittle, P.J. (1990) Trends Biochem. Sci., 15(11), 425-430.
70. Menendez-Arias, L. and Tozser, J. (2007) Trends Pharmacol. Sci., 29(1), 42-49.
71. Clavel, F.; Guetard, D.; Brun-Vezinet, F.; Chamaret, S.; Rey, M.A.; Santos-Ferreira, M.O.; Laurent, A.G.; Dauguet, C.; Katlama, C. and Rouzioux, C. (1986) Science, 233(4761), 343-346.
72. Zhou, L.; Yang, Q.; Wang, Y.; Hu, Y.; Luo, X.; Bai, D. and Li, S. (2008) Chem. Pharm. Bull., 56(8), 1147-1152.
73. Palella, F.J. Jr.; Delaney, K.M.; Moorman, A.C.; Loveless, M.O.; Fuhrer, J.; Satten, G.A.; Aschman, D.J. and Holmberg, S.D. (1998) N. Engl. J. Med., 338(13), 853-860.
74. Mocroft, A.; Vella, S.; Benfield, T.L.; Chiesi, A.; Miller, V.; Gargalianos, P.; d'Arminio Monforte, A.; Yust, I.; Bruun, J.N.; Phillips, A.N. and Lundgren, J.D. (1998) Lancet, 352(9142), 1725-1730.
75. Condra, J.H.; Schleif, W.A.; Blahy, O.M.; Gabryelski, L.J.; Graham, D.J.; Quintero, J.C.; Rhodes, A.; Robbins, H.L.; Roth, E. and Shivaprakash, M. (1995) Nature, 374(6522), 569-571.
76. Boden, D. and Markowitz, M. (1998) Anitimicrob. Agents Chemother., 42(11), 2775-2783.
77. Walli, R.; Herfort, O.; Michl, G.M.; Demant, T.; Jager, H.; Dieterle, C.; Bogner, J.R.; Landgraf, R. and Goeble, F.D. (1998) AIDS, 12(15), 167-173.
78. Lo, J.C.; Mulligan, K.; Tai, V.W.; Algren, H. and Schambelan, M. (1998) Lancet, 351(9106), 867-870.
79. Miller, K.D.; Jones, E.; Yanovski, J.; Shankar, R.; Feuerstein, I. and Falloon, J. (1998) Lancet, 351(9106), 871-875.
80. Carr, A.; Samaras, K.; Burton, S.; Law, M.; Freund, J.; Chisholm, D.J. and Cooper, D.A. (1998) AIDS, 12(7), 51-58.
81. Viraben, R. and Aquilina, C. (1998) AIDS, 12, 37-39.
82. Martinez, E.; Casamitjana, R.; Conget, I. and Gatell, J.M. (1998) AIDS, 12(15), 2077-2079.
83. Tomasselli, A.G. and Heinriskson, R.L. (2000) Biochim. Biophys. Act., 1477(1-2), 189-214.
84. Youle, M. (2007) J. Antimicrob. Chemother., 60(6), 1195-205.
85. Lamarre, D.; Croteau, G.; Wardrop, E.; Bourgon, L.; Thibeault, D.; Clouette, C.; Vaillancourt, M.; Cohen, E.; Pargellis, C.; Yoakim, C. and Anderson, P.C. (1997) Antimicrob. Agents Chemother., 41(5), 965-971.
86. Musial, B.L.; Chojnacki, J.K. and Coleman, C.I. (2004) Am. J. Health-Syst. Pharm., 61(13), 1365-1374.
87. Orrick, J.J. and Steinhart, C.R. (2004) Ann. Pharmacother., 38(10), 1664-1674.
88. Robinson, B.S.; Riccardi, K.A.; Gong, Y.; Guo, Q.; Stock, D.A.; Blair, W.S.; Terry, B.J.; Deminie, C.A.; Djang, F.; Colonno, R.J. and Lin, P. (2000) Antimicrob. Agents Chemother., 44(8), 2093-2099.
89. Lu, H.; Isralewitz, B.; Krammer, A.; Vogel, V. and Schulten, K. (1998) Biophys. J., 75(2), 662-671.
90. Lu, H. and Schulten, K. (2000) Biophys. J., 79(1), 51-65.
91. Gao, M.; Lu, H. and Schulten, K. (2002) J. Muscle Res. Cell Motil., 23(5-6), 513-521.
92. Ortiz, V.; Nielsen, S.O.; Klein, M.L. and Discher, D.E. (2005) J. Mol. Biol., 349(3), 638-647.
93. Paramore, S. and Voth G. A. (2006) Biophys. J., 91(9), 3436-3445.
94. Sotomayor, M.; Corey, D.P. and Schulten, K. (2005) Structure, 13(4), 669-682.